Prevalence of active hepatitis C virus infection in patients with systemic lupus erythematosus

American Journal of the Medical Sciences

Volumn 331, Issue 5, 2006, Pages 252-256

  Ahmed, M Mubashir ^a,b   Berney, Seth Mark ^a   Wolf, Robert E ^a   Hearth Holmes, Michelene ^a   Hayat, Samina ^a   Mubashir, Eisha ^a   Vanderheyde, Henri ^c   Chang, Wun Ling ^a   King, John W ^b  

^a Louisiana State University School of Medicine Shreveport   (United States)

^b LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^c NONE

Author keywords

Extrahepatic manifestation; Hepatitis C virus; Systemic lupus erythematosus

Indexed keywords

ADULT; ARTICLE; BLOOD DONOR; CLINICAL ARTICLE; DISEASE ASSOCIATION; FEMALE; GEOGRAPHIC DISTRIBUTION; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; MALE; PATHOGENESIS; POLYMERASE CHAIN REACTION; PREVALENCE; STATISTICAL SIGNIFICANCE; SYSTEMIC LUPUS ERYTHEMATOSUS; UNITED STATES; VIREMIA;

ADULT; AUTOANTIBODIES; BLOOD DONORS; FEMALE; HEPACIVIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; LOUISIANA; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; PREVALENCE; RNA, VIRAL; VIRAL LOAD;

EID: 33744493116     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000441-200605000-00003     Document Type: Article

References (33)

1. Perlemuter G, Cacoub P, Sbai A, et al. Hepatitis C virus in SLE. J Rheumatol 2003;30:1473-8.
2. Cacoub P, Renou C, Rosenthal E, et al. Extrahepatic manifestations associated with hepatitis C virus infection: a prospective multicenter study of 321 patients. Medicine (Baltimore) 2000;79:47-56.
3. Denman AM. Systemic lupus erythematosus: is a viral etiology a credible hypothesis? J Infect 2000;40:229-33.
4. Obermayer-Straub P, Manns M. Hepatitis C and D: retroviruses and autoimmune manifestations. Autoimmun 2001;16:275-285.
5. Ramos-Casals M, Font J, Garcia-Carrasco M, et al. Hepatitis C virus infection mimicking systemic lupus erythematosus. Arthritis Rheum 2000;43:2801-6.
6. Cacoub P, Poynard T, Ghallani P, et al. Extrahepatic manifestations of chronic hepatitis C. MULTIVIRC Group. Multidepartment Virus C Arthritis Rheum 1999;42:2204-12.
7. Wilson LE, Widman D, Dickman SH, et al. Autoimmune disease complicating antiviral therapy for hepatitis C virus infection. Semin Arthritis Rheum 2002;32:163-73.
8. Marchesoni A, Battafarano N, Podico M, et al. Hepatitis C virus antibodies and systemic lupus erythematosus [letter]. Clin Exp Rheumatol 1995;13:267.
9. Kowdley KV, Subler DE, Scheffel J, et al. Hepatitis C virus antibodies in systemic lupus erythematosus. J Clin Gastroenterol 1997;25:437-9.
10. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
11. Alter M, Kruszon-Moran D, Nainan O, et al. The prevalence of hepatitis C virus in United States, 1988 through 1994. N Engl J Med. 1999 Aug 19;341:556-62.
12. Jorgensen PA, Neuwald PD. Standardized hepatitis C virus RNA panels for nucleic acid testing assays. J Clin Virol 2001;20:35-40.
13. Ramos-Casals M, Garcia-Carrasco M, Cervera R, et al. Hepatitis C virus mimicking primary Sjogren's syndrome: a clinical and immunologic description of 35 cases. Medicine 2001;80:1-8.
14. Ramos-Casals M, García-Carrasco M, Cervera R, et al. Sjögren's syndrome and hepatitis C virus. Clin Rheumatol 1999;18:93-100.
15. Fine KD, Ogunji F, Saloum Y, et al. Celiac sprue: another autoimmune syndrome associated with hepatitis C. Am J Gastroenterol 2001;96:138-45.
16. Frustaci , Calabrese F, Chimenti C, et al. Lone hepatitis C virus myocarditis responsive to immunosuppressive therapy. Chest 2002;122:1348-56.
17. Starkebaum G, Sasso E. Hepatitis C and B cells: induction of autoimmunity and lymphoproliferation may reflect chronic stimulation through cell-surface receptors [editorial]. J Rheumatol 2004;31:416-8.
18. Ramos-Casals M, Trejo O, Garcia-Carrasco M, et al. Triple association between HCV infection, systemic autoimmune diseases, and B cell lymphoma. J Rheumatol 2004;31:495-9.
19. Lunel F, Cacoub P. Treatment of autoimmune and extrahepatic manifestations of HCV infection. Ann Med Interne 2000;151:58-64.
20. Danesh FR, Lynch P, Kanwar YS. Lupus membranous glomerulonephritis mimicking hepatitis C-associated nephropathy. Am J Kidney Dis 2002;39:E19.
21. Cacoub P, Lunel F, Huong LT. Polyarteritis nodosa and hepatitis C virus infection [letter]. Ann Intern Med 1992;116:605-6.
22. Marvisi M. A case of systemic lupus erythematosus or hepatitis C virus? [letter] Chest 1998;113:1146.
23. Nepveu K, Libman B. Hepatitis C virus as another possible cause of porphyria cutanea tarda and systemic lupus erythematosus. Arthritis Rheum 1996;39:352-4.
24. Sanchez-Tapias JM, Barrera JM, Costa J, et al. Hepatitis C virus infection in patients with nonalcoholic chronic liver disease. Ann Intern Med 1990;112:921-4.
25. Fuyukawa S, Kajiwara E, Suzuki N, et al. Systemic lupus erythematosus after interferon therapy for chronic hepatitis C: a case report and review of the literature. Am J Gastroenterol 2000;95:310-2.
26. Cacoub P, Sbai A, Frances C, et al. Systemic sarcoidosis during interferon-alpha therapy for chronic hepatitis C virus infection. Gastroenterol Clin Biol 2000;24:364-6.
27. Sanchez-Pobre P, Gonzalez C, Paz E, et al. Chronic hepatitis C and autoimmune cholangitis: a case study and literature review. Dig Dis Sci 2002;47:1224-9.
28. Gurtubay IG, Morales G, Arechaga O, et al. Development of myasthenia gravis after interferon alpha therapy. Electromyogr Clin Neurophysiol 1999;39:75-8.
29. Eibl N, Gschwantler M, Ferenci P, et al. Development of insulin-dependent diabetes mellitus in a patient with chronic hepatitis C during therapy with interferon-alpha. Eur J Gastroenterol Hepatol 2001;13:295-8.
30. Passos de Sousa E, Evangelista Segundo PT, Jose FF, et al. Rheumatoid arthritis induced by alpha-interferon therapy. Clin Rheumatol 2001;20:297-9.
31. Ward DL, Bing-You RG. Autoimmune thyroid dysfunction induced by interferon-alpha treatment for chronic hepatitis C: screening and monitoring recommendations. Endocr Pract 2001;7:52-8.
32. Parana R, Cruz M, Santos-Jesus R, et al. Thyroid disease in HCV carriers undergoing antiviral therapy with interferon plus ribavirin. Braz J Infect Dis 2000;4:284-90.
33. Bell TM, Bansal AS, Shorthouse C, et al. Low-titer autoantibodies predicts autoimmune disease during interferon-alpha treatment of chronic hepatitis C. J Gastroenterol Hepatol 1999;14:419-22.